Onyx Biotec Shareholding Pattern & Promoter Holding

Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026

As of Sep 2026, promoters hold 41.74% of Onyx Biotec, FIIs hold 0.22%, DIIs hold 2.39% and the public holds 55.64%. Promoter holding fell by 23.36 percentage points from Mar 2026.

Get an alert when Onyx Biotec reports results or its shareholding changes. Free account.

Promoters

41.74%

−23.36 pp QoQ

FIIs

0.22%

−0.85 pp QoQ

DIIs

2.39%

unchanged QoQ

Public

55.64%

+24.20 pp QoQ

Onyx Biotec shareholding, quarter by quarter

QuarterPromotersFIIsDIIsPublicShareholders
Sep 202641.74%0.22%2.39%55.64%631
Mar 202665.10%1.07%2.39%31.44%586
Sep 202565.10%1.95%2.39%30.56%640
Mar 202565.10%5.36%2.39%27.15%551
Nov 202465.10%8.72%3.29%22.89%1,181

Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.

Onyx Biotec shareholding: common questions

What is the promoter holding in Onyx Biotec?

Promoters hold 41.74% of Onyx Biotec as of Sep 2026. Their stake fell by 23.36 percentage points from Mar 2026.

How much do FIIs hold in Onyx Biotec?

Foreign institutional investors (FIIs) held 0.22% of Onyx Biotec in Sep 2026, −0.85 pp versus Mar 2026.

How much do mutual funds and other DIIs hold in Onyx Biotec?

Domestic institutional investors (DIIs), which include mutual funds and insurers, held 2.39% of Onyx Biotec in Sep 2026, unchanged versus Mar 2026.

Is the promoter holding in Onyx Biotec pledged?

The latest disclosed shareholding pattern shows no pledged promoter shares in Onyx Biotec.

How has Onyx Biotec's promoter holding changed in the last year?

Promoter holding moved from 65.10% in Nov 2024 to 41.74% in Sep 2026 (−23.36 pp).

How many shareholders does Onyx Biotec have?

Onyx Biotec had 631 shareholders in Sep 2026, compared with 586 in Mar 2026.